A unified platform for the rapid assembly of glutarimides for Cereblon E3 ligase modulatory drugs

D David M. Whalley O Olivier Lorthioir N Niall A. Anderson E Erin Braybrooke S Susannah C. Coote S Sylvain Demanze H Holly L. Douglas O Okky Dwichandra Putra (Early Product Development and Manufacturing, Pharmaceutical Sciences, R&D) K Katie Proctor Y Yuanyuan Si S Sam Staniland S Stephen Stokes A Alfie Woodhouse

Abstract

Abstract Glutarimide-containing Cereblon (CRBN) ligands are critical motifs for PROTACs, molecular glue degraders and next-generation Cereblon E3 ligase modulatory drugs (CELMoDs), which represent promising therapeutic modalities in targeted protein degradation. However, the multistep synthetic routes required to access glutarimide scaffolds continue to present formidable challenges for medicinal chemists, limiting rapid structure–activity relationship (SAR) exploration and late-stage diversification. To streamline access to these privileged motifs, modular and efficient methodologies are still highly desirable. Here, we report a unified organocatalytic synthesis platform for the rapid assembly of diverse glutarimide derivatives from readily available nitrogen heterocycles. Employing a sequence of phosphine-catalysed C–N bond formation, metal-free Giese addition and acid-mediated cyclisation, this approach provides high selectivity, broad functional group tolerance and operational simplicity under conditions amenable to both multigram synthesis and high-throughput parallel synthesis. Using this platform, we rapidly prepare CRBN binder libraries, access control analogues (for example, N ‑alkylated glutarimides) and perform late‑stage functionalisation of bioactive molecules. This strategy could offer a transformative solution for the efficient and cost-effective synthesis of CRBN-targeted therapeutics and chemical biology probes, overcoming longstanding synthetic bottlenecks in the field.

Article Details

Volume / Issue Vol. 17, Issue 1
Published June 21, 2026
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (13)

D

David M. Whalley

O

Olivier Lorthioir

N

Niall A. Anderson

E

Erin Braybrooke

S

Susannah C. Coote

S

Sylvain Demanze

H

Holly L. Douglas

O

Okky Dwichandra Putra

Early Product Development and Manufacturing, Pharmaceutical Sciences, R&D

K

Katie Proctor

Y

Yuanyuan Si

S

Sam Staniland

S

Stephen Stokes

A

Alfie Woodhouse